CRA is a proud sponsor of the the epicenter of the specialty pharmacy industry event.
Becky Davis presents the session titled “GLP-1s: Riding the Wave of Innovative Medications”
GLP-1s are taking the nation by storm and there appears to be no end in sight! With current indications in diabetes, obesity, and cardiovascular disease and an active pipeline in a wide variety of other conditions ranging from substance abuse to Alzheimer’s disease to Chronic Kidney disease , what’s in store for this large and growing category? And how will US payers approach coverage and management given the complexity of patient co-morbidities?
For more information on this event, click here.
